Sionna Therapeutics Inc
(SION)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Operating Expenses | 70,556 | 50,333 |
| Operating Income | -70,556 | -50,333 |
| Other Income | 8,868 | 3,070 |
| Pre-tax Income | -61,688 | -47,263 |
| Net Income Continuous | -61,688 | -47,263 |
| Net Income | $-61,688 | $-47,263 |
| EPS Basic Total Ops | -15.99 | -16.11 |
| EPS Basic Continuous Ops | -15.99 | -16.11 |
| EPS Diluted Total Ops | -15.99 | -16.11 |
| EPS Diluted Continuous Ops | -15.99 | -16.11 |
| EPS Diluted Before Non-Recurring Items | -15.99 | N/A |
| EBITDA(a) | $-72,889 | $-50,429 |